Oncotarget · 2016 · 101 citations · 27 references
Life SciencesBiochemistryOncologyBreast OncologyMetabolomicsMolecular OncologyCancer MetabolomicsClinical MetabolomicsMetabolite IdentificationMetabolite ProfilingBreast Cancer Molecular SubtypesClinical Metabolite ProfilingDifferential Metabolite AnalysisMetabolic Signature DiscoveryMetabolomic Biomarker DiscoveryMetabolomic SignaturesMetabolomic Tumor MarkersUntargeted Metabolomics Analysis
// Yong Fan 1, * , Xin Zhou 2, * , Tian-Song Xia 3, * , Zhuo Chen 1 , Jin Li 1 , Qun Liu 1 , Raphael N Alolga 1 , Yan Chen 4 , Mao-De Lai 1 , Ping Li 1 , Wei Zhu 2 , Lian-Wen Qi 1 1 State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China 2 Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China 3 Department of Breast Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China 4 Emergency Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China * These authors have contributed equally to this work Correspondence to: Lian-Wen Qi, e-mail: qilw@cpu.edu.cn Ping Li, e-mail: liping2004@126.com Wei Zhu, e-mail: zhuwei1983213@163.com Keywords: human plasma metabolomics, differential metabolites, molecular subtypes, breast cancer Received: September 04, 2015     Accepted: January 23, 2016     Published: February 03, 2016 ABSTRACT Purpose: This work aims to identify differential metabolites and predicting molecular subtypes of breast cancer (BC). Methods: Plasma samples were collected from 96 BC patients and 79 normal participants. Metabolic profiles were determined by liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry based on multivariate statistical data analysis. Results: We observed 64 differential metabolites between BC and normal group. Compared to human epidermal growth factor receptor 2 (HER2)-negative patients, HER2-positive group showed elevated aerobic glycolysis, gluconeogenesis, and increased fatty acid biosynthesis with reduced Krebs cycle. Compared with estrogen receptor (ER)-negative group, ER-positive patients showed elevated alanine, aspartate and glutamate metabolism, decreased glycerolipid catabolism, and enhanced purine metabolism. A panel of 8 differential metabolites, including carnitine, lysophosphatidylcholine (20:4), proline, alanine, lysophosphatidylcholine (16:1), glycochenodeoxycholic acid, valine, and 2-octenedioic acid, was identified for the classification of BC subtypes. These markers showed potential diagnostic value with average area under the curve at 0.925 (95% CI 0.867-0.983) for the training set ( n =51) and 0.893 (95% CI 0.847-0.939) for the test set ( n =45). Conclusion: Human plasma metabolomics is useful in identifying differential metabolites and predicting breast cancer subtypes.
27
Molecular portraits of human breast tumours
Charles M. Perou, Thérese Sørlie, Michael B. Eisen et al. · Nature · 2000 · 16.3K citations
Otto Warbürg · Science · 1956 · 13.3K citations
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2015 · 11.9K citations · Full text